Latest News about MNMD
Recent news which mentions MNMD
From TalkMarkets
'Big 5" Psychedelic-Based Biotech Stocks Up 34% YTD
August 19, 2025
From TalkMarkets
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today
August 12, 2025
Tickers
MNMD
From Motley Fool
Earnings Scheduled For July 31, 2025
July 31, 2025
From Benzinga
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
May 24, 2025
From Benzinga
Tickers
MNMD
From Motley Fool
From Benzinga
Earnings Scheduled For May 8, 2025
May 08, 2025
From Benzinga
From Benzinga
Earnings Scheduled For March 6, 2025
March 06, 2025
From Benzinga
Warren Buffett's State of the Market
March 03, 2025
From Motley Fool
This Westlake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
January 28, 2025
From Benzinga
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
November 29, 2024
From Motley Fool
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
November 13, 2024
From Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
From Benzinga
MNMD Stock Earnings: Mind Medicine Misses EPS for Q2 2024
August 13, 2024
Tickers
MNMD
From InvestorPlace
From Benzinga
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
July 31, 2024
From Benzinga
3 Psychedelic Stocks to Ride to the Moon and Beyond
July 06, 2024
From InvestorPlace
From InvestorPlace
Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M
June 26, 2024
From Benzinga
From InvestorPlace
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.